enquiries@govgrant.co.uk
01727 738600
Contact us
GovGrant R&D specialists logo

Covid-19 update: Read more

Latest R&D tax relief scheme changes, as announced in the Autumn Budget 2021

Posted on Thursday 2 December 2021 by Luke Hamm | Chief Executive Officer

What was announced in the Autumn Budget 2021 concerning R&D tax credits?

Following on from that consultation reforms that were announced in the Autumn Budget 2021, the government:

  • support modern research methods by expanding qualifying expenditure to include data and cloud costs
  • more effectively capture the spillover benefits of R&D funded by the reliefs through refocusing support towards innovation in the UK
  • target abuse and improve compliance

Today we got more of the detail of these reforms and understood more of the next steps.
> Read more

Day of reckoning for unscrupulous R&D tax providers as HMRC comes calling

Posted on Thursday 4 November 2021 by Luke Hamm | Chief Executive Officer

The latest statistics showing the value of R&D tax relief were published by HMRC in October 2021. And as we noted at the time the total value of R&D tax relief for 2019-2020 is now projected to be nearly £7.5bn – a big number.
> Read more

HMRC’s statistics for R&D and Patent Box tax relief – GovGrant commentary

Posted on Friday 1 October 2021 by Luke Hamm | Chief Executive Officer

The latest statistics showing the value of R&D tax relief and Patent Box were published by HMRC yesterday. What does an initial look at this year’s numbers tell us?
> Read more

R&D tax credit calculator – What is it really telling you?

Posted on Thursday 19 November 2020 by Luke Hamm | Chief Executive Officer

We know that a lot of competitors have a “calculator” on their website or examples of R&D claims. We’ve never felt that this was necessary, not because it’s difficult or mysterious – but because it asks the wrong question and therefore gives you the wrong answer.
> Read more

Furlough and R&D tax credits: Can you claim relief?

Posted on Wednesday 16 September 2020 by Vanessa Cooper | Group Technical Tax Manager

We have had some clarification from HMRC on how companies furloughing staff deal with claims under the SME R&D tax relief or Research and Development Expenditure Credit (RDEC) schemes. It’s important to realise that the rules are different under each of these schemes. But also that small and medium enterprises can claim under the RDEC scheme.
> Read more

HMRC confirms the State Aid rules for each new Covid-19 loan scheme

Posted on Friday 29 May 2020 by Vanessa Cooper | Group Technical Tax Manager

GovGrant sits on the Research & Development Consultative Committee (RDCC) to represent UK’s business when it comes to the operational delivery of the R&D tax relief schemes. This is an HMRC-sponsored forum, and as members we receive regular updates as HMRC advice evolves and develops. We are currently in an unprecedented period of change, with the introduction of new and vital measures to support business British business.> Read more

R&D Tax Credits: doing nothing is not an option

Posted on Tuesday 15 October 2019 by Luke Hamm | Chief Executive Officer

In their latest podcast, Accountancy Age spoke to GovGrant’s CEO, Luke Hamm, about the need for the R&D tax credit programme to be kickstarted in the UK in order to drive much-needed innovation. In this entertaining podcast, we cover why the government must do more, how businesses of all sizes are missing out, the regional problem and why the big four need to take some of the blame for the issue.

> Read more

Medtech and biopharma can drive the UK growth agenda and more support should be given

Posted on Friday 3 May 2019 by Luke Hamm | Chief Executive Officer

The UK’s biopharma and medtech sector is a world class sector with potential for stellar growth, according to Luke Hamm, CEO of GovGrant, which helps companies in the sector obtain commercialise their innovations, including R&D tax credits. Commenting after the publication of the government’s Office For Life Science’s (OLS) statistical survey of biotech and medtech in the UK, Luke said: “The report underlines the vital importance of this sector to the UK economy, with a quarter of a million employees, turnover of nearly £75bn and over 6,000 businesses across the four key areas.” [biopharma, biopharma service and supply, med tech core and med tech supplier businesses.]

> Read more

GovGrant urges Chancellor not to go ‘down under’ for innovation and R&D tax policy ideas

Posted on Monday 18 February 2019 by Luke Hamm | Chief Executive Officer

Australian government proposals to restrict tax incentives for R&D and innovation have been delayed following an outcry from business and research groups. The proposals, intended to save £1.2bn capped cash refunds for research activities at $4m, introduced a new ‘intensity test’ for larger companies to favour higher, more intensive R&D investment, and significantly increased compliance and enforcement measures, according to a report in the Guardian newspaper.

> Read more

Follow us

Recent posts

Tomcat SNI – inventions with a social purpose

Latest R&D tax relief scheme changes, as announced in the Autumn Budget 2021

Budget 2021: What does it mean for R&D and innovation?

Is there enough investment in climate change solutions? What the numbers tell us.

Day of reckoning for unscrupulous R&D tax providers as HMRC comes calling

Categories

Accountants

Capital allowances

Chancellor’s Budget

Client experience

Covid-19

Events and Training

For investors

Government policy

GovGrant people

HMRC tax

Innovation and Technology

Intellectual Property Services

Investors

Patent Box

R&D tax relief

RDEC

SMEs

Universities